In what geographic regions is Sepracor hiring sales professionals?
Sepracor is always looking for experienced sales candidates nationwide. We try to match your interests as best we can with the openings available. Click here for a list of our available openings.

What is a typical starting salary for a Sepracor sales career? Starting salaries are individual decisions based on several criteria, including your experience. All offers are competitive and offer performance-based incentive plans. They are determined at the time a decision is made to extend an offer. To begin your job search, click here.

What career development opportunities are there? Sepracor offers many career growth opportunities that are endorsed formally through our Career Development Program and informally through opportunities identified by individual departments. Your performance, interests, length of service and flexibility are key to determining how to best take advantage of them. To begin your job search, click here.

What benefits does Sepracor provide?
Our comprehensive benefits package includes medical, dental, 401(k), life insurance, employee stock purchase plan, tuition reimbursement and much more. Click here for more information.

What products does Sepracor currently have on the market?
We currently commercialize six products, LUNESTA^® brand eszopiclone; XOPENEX^® brand levalbuterol HCl Inhalation Solution; XOPENEX HFA^® brand levalbuterol tartrate Inhalation Aerosol, a hydrofluoroalkane (HFA) metered-dose inhaler (MDI); BROVANA^® brand arformoterol tartrate Inhalation Solution; OMNARIS^® brand ciclesonide Nasal Spray; and ALVESCO^® brand ciclesonide HFA Inhalation Aerosol.

How extensive is Sepracor's pipeline?
Sepracor has several compounds in various stages of development. Sepracor's drug development pipeline includes drug candidates SEP-225289, a novel triple reuptake inhibitor for the treatment of depression, SEP-227162, an antidepressant candidate, SEP-0227018, our new formulation of LUNESTA for the treatment of insomnia, SEP-228432 for the treatment of depression and ADHD, and SEP-227900 for neuropathic pain, as well as several additional targets in preclinical trials. Click here to learn more about our pipeline.

Where can I find more information on Sepracor?
You can learn more about careers at Sepracor here, and more about our corporation here.